Advertisement

 

 

A Cost-Effectiveness Analysis Of Pre-Exposure Prophylaxis For The Prevention Of HIV Among Los Angeles County Men Who Have Sex With Men.

A Cost-Effectiveness Analysis Of Pre-Exposure Prophylaxis For The Prevention Of HIV Among Los Angeles County Men Who Have Sex With Men.
Author Information (click to view)

Drabo EF, Hay JW, Vardavas R, Wagner ZR, Sood N,


Drabo EF, Hay JW, Vardavas R, Wagner ZR, Sood N, (click to view)

Drabo EF, Hay JW, Vardavas R, Wagner ZR, Sood N,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016 8 23() pii

Abstract
BACKGROUND
 Substantial gaps remain in understanding the trade-offs between the costs and benefits of choosing alternative HIV prevention strategies, including Test-and-Treat (expanded HIV testing combined with immediate treatment), and PrEP (initiation of pre-exposure prophylaxis [PrEP] by high risk uninfected individuals) strategies.

METHODS
 We develop a mathematical epidemiological model to simulate HIV incidence among men residing in Los Angeles County, CA, aged 15-65 year, who have sex with men.We combine these incidence data with an economic model to estimate the discounted cost, effectiveness (quality-adjusted life years [QALYS]) and incremental cost-effectiveness ratios (ICERs) of various HIV prevention strategies using a societal perspective and a lifetime horizon.

RESULTS
 PrEP and Test-and-Treat yield the largest reductions in HIV incidence, and are highly cost-effective ($27863/QALY and $19302/QALY, respectively) relative to Status Quo and at a US willingness-to-pay threshold of $150000/QALY saved. Status Quo and twelve Test-and-Treat and PrEP strategies determine the frontier for efficient decisions. More aggressive strategies are costlier, but more effective, albeit with diminishing returns. The relative effectiveness of PrEP is sensitive to the initial HIV prevalence rate, PrEP and ART adherence and initiation rates, the probabilities of HIV transmission, and the rates of sexual partner mixing.

CONCLUSIONS
 PrEP and Test-and-Treat offer cost-effective alternatives to the Status Quo. The success of these strategies depends on ART and PrEP adherence and initiation rates. The lack of evidence on adherence behaviors toward PrEP, therefore, warrants further studies.

Submit a Comment

Your email address will not be published. Required fields are marked *

eighteen − one =

[ HIDE/SHOW ]